Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Oxford Nanopore Technologies PLC ( (GB:ONT) ) has shared an announcement.
Oxford Nanopore Technologies plc disclosed that its Chief Financial Officer, Nicholas Keher, has acquired 22,018 ordinary shares in the company. The purchase, executed on 11 May 2026 at £1.1294 per share on the London Stock Exchange, reflects a personal investment by a senior executive and was reported in line with the UK Market Abuse Regulation requirements.
The transaction underscores regulatory transparency around dealings by persons discharging managerial responsibilities, providing investors with visibility into insider share purchases. Such disclosures can influence market perceptions of management’s confidence in the company’s prospects, even though the announcement itself is primarily a compliance-driven notification.
The most recent analyst rating on (GB:ONT) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.
Spark’s Take on ONT Stock
According to Spark, TipRanks’ AI Analyst, ONT is a Neutral.
The score is held back primarily by weak financial performance—large ongoing losses and continued cash burn—despite improving revenue growth and solid gross margins. Technicals also detract due to a clear downtrend (below major moving averages and negative MACD). Offsetting factors include constructive earnings-call guidance with margin/OpEx discipline and a credible longer-term breakeven timeline, plus a relatively low-leverage balance sheet.
To see Spark’s full report on ONT stock, click here.
More about Oxford Nanopore Technologies PLC
Oxford Nanopore Technologies plc operates in the life sciences and genomics industry, developing and supplying nanopore-based DNA and RNA sequencing technologies. Its products enable real-time, scalable genetic analysis for research, clinical, and industrial applications, targeting customers in academic institutions, healthcare, and biotech sectors.
Average Trading Volume: 1,691,823
Technical Sentiment Signal: Sell
Current Market Cap: £1.1B
Learn more about ONT stock on TipRanks’ Stock Analysis page.